Trials / Completed
CompletedNCT02864823
Perichondrium Autograft in Refractory Necrotizing Scleritis
Autologous Perichondrium Transplantation for Replacement of Stem Cells and Their Niche in the Treatment of Necrotizing Scleritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Chung-Ang University Hosptial, Chung-Ang University College of Medicine · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Necrotizing scleritis with severe ischemia is refractory to conventional treatment because of avascular necrosis. The investigators assessed the therapeutic efficacy and safety of autologous perichondrium transplantation in patients with severe ischemic necrotizing scleritis, and analyzed the therapeutic effects.
Detailed description
Ischemic necrotizing scleritis patients who showed persistent and progressive scleral melting were included in this study. Perichondrium tissue was harvested from the patient's ear cartilage and transplanted to reconstruct the scleral defect after the necrotic tissue removal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Perichondrium Autografts | Perichondrium tissue was harvested from the patient's ear cartilage and transplanted to reconstruct the scleral defect. |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2016-08-12
- Last updated
- 2016-08-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02864823. Inclusion in this directory is not an endorsement.